← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,486개
AntibodystaleRochePhase 2

Bevacizumab； HRS-1167 (Bevacizumab； HRS-1167)

Recurrent Ovarian Cancer · Recurrent Ovarian Cancer

#RecurrentOvarianCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Biological: Bevacizumab, Drug: FOLFOX, Drug: FOLFIRI (Biological: Bevacizumab, Drug: FOLFOX, Drug: FOLFIRI)

Colorectal Cancer; Metastatic Colorectal Cancer With RAS Mutation · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleMerckPhase 1

pembrolizumab (Keytruda, Bortezomib; pembrolizumab and cisplatin injections--bortezomib followed by pembro/cis)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 1

Brivanib + Cetuximab (Brivanib + Cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleFudan UniversityPhase 2

C1: SHR-A1811 (C1: SHR-A1811)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

C2: SHR-A1811 with BP102 (C2: SHR-A1811 with BP102)

Triple-negative Breast Cancer · Triple-negative Breast Cancer

#Triple-negativeBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
CGTBiologicstaleFred Hutchinson Cancer CenterPhase 1

C46/CCR5/P140K Lentiviral Vector-transduced Autologous HSPCs (C46/CCR5/P140K Lentiviral Vector-transduced Autologous HSPCs)

Human Immunodeficiency Virus 1 Positive; Stage I Adult Hodgkin Lymphoma · Human Immunodeficiency Virus 1 Positive

#HumanImmunodeficiencyVirus1Posit#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
CGTBiologicstaleM.D. Anderson Cancer CenterPhase 2

C9/CD5CAR/IL-15 NK cells (C9/CD5CAR/IL-15 NK cells)

Hematological Malignancies · Hematological Malignancies

#HematologicalMalignancies#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 RECRUITING
AntibodystaleNational Cancer Center, KoreaPhase 2

nivolumab (Opdivo, CA and Nivolumab)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleNational Cancer Centre, Singapo…Phase 2

pembrolizumab (Keytruda, CAPEOX/Pembrolizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

CAPOX+ Camrelizumab+ Bevacizumab (CAPOX+ Camrelizumab+ Bevacizumab)

Unresectable Metastatic Rectal Cancer; CAPOX · Unresectable Metastatic Rectal Cancer

#UnresectableMetastaticRectalCanc#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

CAPOX+ Camrelizumab+ Cetuximab (CAPOX+ Camrelizumab+ Cetuximab)

Unresectable Metastatic Rectal Cancer; CAPOX · Unresectable Metastatic Rectal Cancer

#UnresectableMetastaticRectalCanc#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
CGTBiologicstaleM.D. Anderson Cancer CenterPhase 2

CAR T leukapheresis (CAR T leukapheresis)

Large B-cell Lymphoma; B-cell Lymphoma · Large B-cell Lymphoma

#LargeB-cellLymphoma#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 DISCONTINUED
CGTBiologicstaleZhejiang UniversityPhase 1

CAR-NK (CAR-NK)

Pancreatic Cancer Non-resectable · Pancreatic Cancer Non-resectable

#PancreaticCancerNon-resectable#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 ACTIVE
CGTBiologicstaleGuangzhou Yiyang Biological Tec…Phase 1

CAR-T cells to treat advanced lung cancer (CAR-T cells to treat advanced lung cancer)

Advanced Lung Cancer · Advanced Lung Cancer

#AdvancedLungCancer#CGT#Phase1#세포유전치료#CAR-T+2
임상시험 1상태 DISCONTINUED
CGTBiologicstaleGuangzhou Anjie Biomedical Tech…Phase 2

CAR-T combined with PD-1 Knockout T cells (CAR-T combined with PD-1 Knockout T cells)

Advanced Esophageal Cancer · PD-1

#PD-1#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleGuangzhou Anjie Biomedical Tech…Phase 2

CAR-T combining PD-1 Knockout (CAR-T combining PD-1 Knockout)

Lung Neoplasm Malignant; Non-small Cell Lung Cancer · PD-1

#PD-1#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleShenzhen BinDeBio Ltd.Phase 2

CAR-T/TCR-T cells immunotherapy (CAR-T/TCR-T cells immunotherapy)

Esophagus Cancer; Hepatoma · Esophagus Cancer

#EsophagusCancer#CGT#Phase2#세포유전치료#CAR-T+3
효능 ORR 0%임상시험 1상태 ACTIVE
CGTBiologicstaleUNC Lineberger Comprehensive Ca…Phase 1

CAR.B7-H3 (CAR.B7-H3)

Epithelial Ovarian Cancer · B7-H3

#B7-H3#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleUNC Lineberger Comprehensive Ca…Phase 1

CAR.k.28 (CAR.k.28)

Mantle Cell Lymphoma; Follicular Lymphoma · Mantle Cell Lymphoma

#MantleCellLymphoma#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING

36 / 75 페이지

← 이전다음 →